-
Novozymes A/S et al. v. Danisco A/S et al. DC CAFC
- 3:10-cv-00251
- W.D. Wis.
- Judge: Barbara B. Crabb +2
- Filed: 05/11/2010
- Closed: 10/27/2011
- Latest Docket Entry: 11/18/2014
- PACER
- Docket updated daily
2
Plaintiffs
3
Defendants
2
Accused
Products
1
Patent-in-Suit
535
Days in
Litigation
-
Novozymes A/S et al. v. Danisco A/S et al. DC CAFC
- 3:10-cv-00251
- W.D. Wis.
- Judge: Barbara B. Crabb +2
- Filed: 05/11/2010
- Closed: 10/27/2011
- Latest Docket Entry: 11/18/2014
- PACER
- Docket updated daily
Market Sector
Biotech and Pharma
Referred Judge
Assigned Judge
Previously Presiding
Stephen L. Crocker (until 12/18/2011)
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
1 |
An isolated variant of a parent alpha-amylase, wherein: (a) the variant has at least 90% sequence identity to SEQ ID NO: 6, (b) the variant comprises a substitution of serine at position 239 relative to the parent alpha-amylase, using the amino acid
view more
|
Invalid (112)
Entry 968 |
2 |
The variant of claim 1, wherein the variant has at least 95% sequence identity to SEQ ID NO: 6.
|
Invalid (112)
Entry 968 |
3 |
The variant of claim 1, wherein the variant has at least 97% sequence identity to SEQ ID NO: 6.
|
Invalid (112)
Entry 968 |
4 |
The variant of claim 1, wherein the variant has at least 99% sequence identity to SEQ ID NO: 6.
|
Invalid (112)
Entry 968 |
5 |
The variant of claim 1, wherein the parent alpha-amylase is a <i>Bacillus stearothermophilus </i>alpha-amylase.
|
Invalid (112)
Entry 968 |
6 |
The variant of claim 5, wherein the <i>Bacillus stearothermophilus </i>alpha-amylase is the amino acid sequence of SEQ ID NO: 6.
|
Invalid (112)
Entry 968 |
7 |
The variant of claim 1, wherein the variant further comprises an alteration at one or more positions selected from the group consisting of 49, 60, 104, 132, 161, 170, 176, 179, 180, 181, 183, 200, 203, 204, 207, 212, 237, 250, 280, 298, 318, 374,
view more
|
Invalid (112)
Entry 968 |
8 |
A composition comprising the variant of claim 1 and (i) another alpha-amylase; or (ii) one or more enzymes selected from the group consisting of glucoamylase, phytase, and pullalanase.
|
Invalid (112)
Entry 968 |
9 |
An isolated variant of a parent alpha-amylase, wherein: (a) the variant has an amino acid sequence with 1-15 alteration(s) relative to the parent alpha-amylase, wherein (i) the 1-15 alteration(s) are independently selected from an insertion, a
view more
|
Invalid (112)
Entry 968 |
10 |
The variant of claim 9, wherein the alteration(s) are substitution(s).
|
Invalid (112)
Entry 968 |
11 |
The variant of claim 9, wherein the variant has 1 alteration relative to the parent alpha-amylase which is the substitution of the amino acid at position 239.
|
Invalid (112)
Entry 968 |
12 |
The variant of claim 9, wherein the parent alpha-amylase has at least 95% sequence identity to SEQ ID NO: 6.
|
Invalid (112)
Entry 968 |
13 |
The variant of claim 9, wherein the parent alpha-amylase has at least 99% sequence identity to SEQ ID NO: 6.
|
Invalid (112)
Entry 968 |
14 |
The variant of claim 9, wherein one or more alteration(s) are at a position selected from the group consisting of 49, 60, 104, 132, 161, 170, 176, 179, 180, 181, 183, 200, 203, 204, 207, 212, 237, 250, 280, 298, 318, 374, 385, 393, 402, 406, 427,
view more
|
Invalid (112)
Entry 968 |
15 |
A composition comprising the variant of claim 9 and (i) another alpha-amylase or (i) one or more enzymes selected from the group consisting of glucoamylase, phytase.
|
Invalid (112)
Entry 968 |
16 |
An isolated variant of a <i>Bacillus stearothermophilus </i>alpha-amylase, wherein the variant consists of a substitution of serine at position 239 with a different amino acid, using the amino acid sequence of SEQ ID NO: 8 for determining position
view more
|
Invalid (112)
Entry 968 |
17 |
The variant of claim 16, wherein the <i>Bacillus stearothermophilus </i>alpha-amylase is the amino acid sequence of SEQ ID NO: 6.
|
Invalid (112)
Entry 968 |
-
Infringement
Danisco A/S
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Clearflow GC980, GC133, GC608GC358GC358, GC980, GC133, GC608, Spezyme Alpha, Clearflow, GC358 Technical Grade, Spezyme Alpha Technical Grade, Spezyme Alpha NK, Spezyme Alpha WB, BBCA Liq 001, Experimental Amylase F-Type<n>(JO5023), ClearFlow AA, ClearFlow AA NK, ClearFlow AA<n>WBGC358, GC980, GC608, Spezyme Alpha, Clearflow, GC358 Technical Grade, Spezyme Alpha Technical Grade, Spezyme Alpha NK, BBCA Liq 001, Experimental Amylase F-Type<n>(JO5023), ClearFlow AA, ClearFlow AA NKGC980Spezyme Alpha WB, GC 133, Clearflow WB | US 7,713,723 B1 |
1, 2, 3, 4, 5, 8, 9, 10, 11, 12, 13, 15, 16
|
Willful infringement
Entry 816Entry 781 Entry 399 |
Danisco USA Incorporated
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Clearflow GC980, GC133, GC608GC358GC358, GC980, GC608, Spezyme Alpha, Clearflow, GC358 Technical Grade, Spezyme Alpha Technical Grade, Spezyme Alpha NK, BBCA Liq 001, Experimental Amylase F-Type<n>(JO5023), ClearFlow AA, ClearFlow AA NKGC980Spezyme Alpha WB, GC 133, Clearflow WB | US 7,713,723 B1 |
1, 2, 3, 4, 5, 8, 9, 10, 11, 12, 13, 15, 16
|
Willful infringement
Entry 816Entry 781 Entry 399 |
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
GC358GC980Spezyme Alpha WB, GC 133, Clearflow WB | US 7,713,723 B1 |
1, 2, 3, 4, 5, 8, 9, 10, 11, 12, 13, 15, 16
|
Willful infringement
Entry 816Entry 399 |
-
Damages